1,3-Dioxoisoindolin-2-yl cycloheptanecarboxylate

Catalog No.: 
ACAZXH957
CAS No.: 
1967011-59-1
Molecular Formula: 
C16H17NO4
Molecular Weight: 
287.32
1,3-Dioxoisoindolin-2-yl cycloheptanecarboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$229.00InquiryInquiry
100mg98%$333.00InquiryInquiry
250mg98%$471.00InquiryInquiry
1g98%$932.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1,3-Dioxoisoindolin-2-yl cycloheptanecarboxylate
IUPAC Name1,3-dioxoisoindolin-2-yl cycloheptanecarboxylate
Molecular FormulaC16H17NO4
Molecular Weight287.32
SMILESO=C(C1CCCCCC1)ON(C(C2=C3C=CC=C2)=O)C3=O
InChI KeyANCKCWZSMJNPEC-UHFFFAOYSA-N
SynonymCycloheptanecarboxylic acid, 1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl ester;1,3-Dioxoisoindolin-2-yl cycloheptanecarboxylate
CAS No.1967011-59-1

Synthetic Route by SureRoute

1. ACAZXH957 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACZVRG567 route compound structure diagram
    ACZVRG5676557-86-4In Stock
  2. Plus
  3. ACWHOJ803 route compound structure diagram
    ACWHOJ803524-38-9In Stock
  4. Then
  5. ACAZXH957 route product structure diagram
    ACAZXH9571967011-59-1
Inquiry

2. ACAZXH957 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEFPT478 route compound structure diagram
    ACEFPT4781460-16-8In Stock
  2. Plus
  3. ACWHOJ803 route compound structure diagram
    ACWHOJ803524-38-9In Stock
  4. Then
  5. ACAZXH957 route product structure diagram
    ACAZXH9571967011-59-1
Inquiry

3. ACAZXH957 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACZVRG567 route compound structure diagram
    ACZVRG5676557-86-4In Stock
  2. Plus
  3. ACWHOJ803 route compound structure diagram
    ACWHOJ803524-38-9In Stock
  4. Then
  5. ACAZXH957 route product structure diagram
    ACAZXH9571967011-59-1
Inquiry

Comments (0)